1 | body | 36,671 |
2 | fat-free | 311 |
3 | low-molecular | 88 |
4 | spla2-iia | 18 |
5 | fledging | 7 |
6 | lv/body | 7 |
7 | non-tender | 7 |
8 | 1000-grain | 6 |
9 | hplc-tandem | 6 |
10 | quadrupole-time-of-flight | 6 |
11 | liver/body | 5 |
12 | underweight/normal | 5 |
13 | 9-kg | 4 |
14 | heart/body | 4 |
15 | interdialysis | 4 |
16 | medium-molecular | 4 |
17 | deltabody | 3 |
18 | gene-body | 3 |
19 | heart-to-body | 3 |
20 | isotope-ratio | 3 |
21 | lipid-rich/necrotic | 3 |
22 | liver-to-body | 3 |
23 | lung-to-body | 3 |
24 | lvm/body | 3 |
25 | nonfluid | 3 |
26 | recovery-room | 3 |
27 | roundish | 3 |
28 | secretory-burst | 3 |
29 | 1-da | 2 |
30 | 100-seed | 2 |
31 | 150-d | 2 |
32 | birthweight/placental | 2 |
33 | cholesterol/saturated | 2 |
34 | femininity-body | 2 |
35 | heat/initial | 2 |
36 | lv-to-body | 2 |
37 | m/go | 2 |
38 | mass/fat | 2 |
39 | mass/lean | 2 |
40 | normal/healthy | 2 |
41 | obesity-body | 2 |
42 | olanzapine-associated | 2 |
43 | organ/body | 2 |
44 | q-exactive | 2 |
45 | sgx-induced | 2 |
46 | small-muscle | 2 |
47 | torso-equivalent | 2 |
48 | δfat | 2 |
49 | -triolein-labeled | 1 |
50 | 0-28-wk | 1 |
51 | 0.44×body | 1 |
52 | 0.5ml/100g | 1 |
53 | 0.5±1.02kg | 1 |
54 | 1.7×1.4-cm | 1 |
55 | 100/birth | 1 |
56 | 11kg | 1 |
57 | 12,476 | 1 |
58 | 18,312 | 1 |
59 | 1ml/100g | 1 |
60 | 2-clbp/rac | 1 |
61 | 2:1:1.33 | 1 |
62 | 5-asa/sasp | 1 |
63 | 5000mg/kgbody | 1 |
64 | 53,009 | 1 |
65 | 54±1.3gr | 1 |
66 | 5975c | 1 |
67 | a=ideal | 1 |
68 | abdominal/visceral | 1 |
69 | age-body | 1 |
70 | agv/fetal | 1 |
71 | ankylotic | 1 |
72 | areally-normalized | 1 |
73 | attr-fibril | 1 |
74 | bar-orbitrap | 1 |
75 | bitmap | 1 |
76 | body-induced | 1 |
77 | body/organ | 1 |
78 | bw/placental | 1 |
79 | bw=body | 1 |
80 | coetaneous | 1 |
81 | deltacetp | 1 |
82 | deltafat | 1 |
83 | diphoton | 1 |
84 | dose/body | 1 |
85 | ecw/body | 1 |
86 | end-permian | 1 |
87 | endo-urology | 1 |
88 | energy-nutrient | 1 |
89 | extra-intracranial | 1 |
90 | fluid-wall | 1 |
91 | fourier-transfer | 1 |
92 | g/kg/body | 1 |
93 | gammarid | 1 |
94 | gas/liquid/solid | 1 |
95 | gender-targeted | 1 |
96 | ghrelin/body | 1 |
97 | grams/kilogram | 1 |
98 | growth/body | 1 |
99 | half-carcass | 1 |
100 | heat-transferring | 1 |
101 | high-bone | 1 |
102 | high-echoic | 1 |
103 | hundred-achene | 1 |
104 | hyper-fever | 1 |
105 | immunocellular | 1 |
106 | industrial-level | 1 |
107 | intestinal-flora | 1 |
108 | koh/c | 1 |
109 | left‑ventricular | 1 |
110 | length-adjusted | 1 |
111 | lge/lv | 1 |
112 | liquid-chromatography-tandem | 1 |
113 | liquid-chromatography/high-resolution | 1 |
114 | liraglutide-augmented | 1 |
115 | lpr-induced | 1 |
116 | ltq/orbitrap | 1 |
117 | lv-rv | 1 |
118 | macro-molecular | 1 |
119 | marbled | 1 |
120 | membrane-inlet | 1 |
121 | menopausal-related | 1 |
122 | mirtazapine-induced | 1 |
123 | multi-lobulated | 1 |
124 | no-muscle | 1 |
125 | non-evacuated | 1 |
126 | non-fluid | 1 |
127 | nonlal | 1 |
128 | normal-body | 1 |
129 | olanzapine-related | 1 |
130 | oxygen-to-fuel | 1 |
131 | pad/body | 1 |
132 | pain-dependent | 1 |
133 | pelvic-abdominal | 1 |
134 | placenta-fetus | 1 |
135 | pm21 | 1 |
136 | postbody | 1 |
137 | postcontract | 1 |
138 | pre-sg | 1 |
139 | prebody | 1 |
140 | quantitative/qualitative | 1 |
141 | range-weighted | 1 |
142 | results-body | 1 |
143 | risperidone-related | 1 |
144 | rmr/fat-free | 1 |
145 | rock-hard | 1 |
146 | sagb-induced | 1 |
147 | sb5/kg | 1 |
148 | seroperitoneal | 1 |
149 | sexuality/body | 1 |
150 | single-quadrupole | 1 |
151 | single/large | 1 |
152 | smartphone-supported | 1 |
153 | steam-to-fuel | 1 |
154 | subattogram | 1 |
155 | subliming | 1 |
156 | substrate-product | 1 |
157 | subtentorial | 1 |
158 | teq/g | 1 |
159 | torque-body | 1 |
160 | torque/body | 1 |
161 | tripletof | 1 |
162 | trunk-fat | 1 |
163 | unclairified | 1 |
164 | uplc-ltq-orbitrap | 1 |
165 | uplc-q-tof | 1 |
166 | vaquasheen | 1 |
167 | variables-body | 1 |
168 | very-low-birth | 1 |
169 | weight/heart | 1 |
170 | work/body | 1 |
171 | €16/kg | 1 |
1 | -triolein-labeled | 1 |
2 | 0-28-wk | 1 |
3 | 0.44×body | 1 |
4 | 0.5ml/100g | 1 |
5 | 0.5±1.02kg | 1 |
6 | 1-da | 2 |
7 | 1.7×1.4-cm | 1 |
8 | 100-seed | 2 |
9 | 100/birth | 1 |
10 | 1000-grain | 6 |
11 | 11kg | 1 |
12 | 12,476 | 1 |
13 | 150-d | 2 |
14 | 18,312 | 1 |
15 | 1ml/100g | 1 |
16 | 2-clbp/rac | 1 |
17 | 2:1:1.33 | 1 |
18 | 5-asa/sasp | 1 |
19 | 5000mg/kgbody | 1 |
20 | 53,009 | 1 |
21 | 54±1.3gr | 1 |
22 | 5975c | 1 |
23 | 9-kg | 4 |
24 | a=ideal | 1 |
25 | abdominal/visceral | 1 |
26 | age-body | 1 |
27 | agv/fetal | 1 |
28 | ankylotic | 1 |
29 | areally-normalized | 1 |
30 | attr-fibril | 1 |
31 | bar-orbitrap | 1 |
32 | birthweight/placental | 2 |
33 | bitmap | 1 |
34 | body | 36,671 |
35 | body-induced | 1 |
36 | body/organ | 1 |
37 | bw/placental | 1 |
38 | bw=body | 1 |
39 | cholesterol/saturated | 2 |
40 | coetaneous | 1 |
41 | deltabody | 3 |
42 | deltacetp | 1 |
43 | deltafat | 1 |
44 | diphoton | 1 |
45 | dose/body | 1 |
46 | ecw/body | 1 |
47 | end-permian | 1 |
48 | endo-urology | 1 |
49 | energy-nutrient | 1 |
50 | extra-intracranial | 1 |
51 | fat-free | 311 |
52 | femininity-body | 2 |
53 | fledging | 7 |
54 | fluid-wall | 1 |
55 | fourier-transfer | 1 |
56 | g/kg/body | 1 |
57 | gammarid | 1 |
58 | gas/liquid/solid | 1 |
59 | gender-targeted | 1 |
60 | gene-body | 3 |
61 | ghrelin/body | 1 |
62 | grams/kilogram | 1 |
63 | growth/body | 1 |
64 | half-carcass | 1 |
65 | heart-to-body | 3 |
66 | heart/body | 4 |
67 | heat-transferring | 1 |
68 | heat/initial | 2 |
69 | high-bone | 1 |
70 | high-echoic | 1 |
71 | hplc-tandem | 6 |
72 | hundred-achene | 1 |
73 | hyper-fever | 1 |
74 | immunocellular | 1 |
75 | industrial-level | 1 |
76 | interdialysis | 4 |
77 | intestinal-flora | 1 |
78 | isotope-ratio | 3 |
79 | koh/c | 1 |
80 | left‑ventricular | 1 |
81 | length-adjusted | 1 |
82 | lge/lv | 1 |
83 | lipid-rich/necrotic | 3 |
84 | liquid-chromatography-tandem | 1 |
85 | liquid-chromatography/high-resolution | 1 |
86 | liraglutide-augmented | 1 |
87 | liver-to-body | 3 |
88 | liver/body | 5 |
89 | low-molecular | 88 |
90 | lpr-induced | 1 |
91 | ltq/orbitrap | 1 |
92 | lung-to-body | 3 |
93 | lv-rv | 1 |
94 | lv-to-body | 2 |
95 | lv/body | 7 |
96 | lvm/body | 3 |
97 | m/go | 2 |
98 | macro-molecular | 1 |
99 | marbled | 1 |
100 | mass/fat | 2 |
101 | mass/lean | 2 |
102 | medium-molecular | 4 |
103 | membrane-inlet | 1 |
104 | menopausal-related | 1 |
105 | mirtazapine-induced | 1 |
106 | multi-lobulated | 1 |
107 | no-muscle | 1 |
108 | non-evacuated | 1 |
109 | non-fluid | 1 |
110 | non-tender | 7 |
111 | nonfluid | 3 |
112 | nonlal | 1 |
113 | normal-body | 1 |
114 | normal/healthy | 2 |
115 | obesity-body | 2 |
116 | olanzapine-associated | 2 |
117 | olanzapine-related | 1 |
118 | organ/body | 2 |
119 | oxygen-to-fuel | 1 |
120 | pad/body | 1 |
121 | pain-dependent | 1 |
122 | pelvic-abdominal | 1 |
123 | placenta-fetus | 1 |
124 | pm21 | 1 |
125 | postbody | 1 |
126 | postcontract | 1 |
127 | pre-sg | 1 |
128 | prebody | 1 |
129 | q-exactive | 2 |
130 | quadrupole-time-of-flight | 6 |
131 | quantitative/qualitative | 1 |
132 | range-weighted | 1 |
133 | recovery-room | 3 |
134 | results-body | 1 |
135 | risperidone-related | 1 |
136 | rmr/fat-free | 1 |
137 | rock-hard | 1 |
138 | roundish | 3 |
139 | sagb-induced | 1 |
140 | sb5/kg | 1 |
141 | secretory-burst | 3 |
142 | seroperitoneal | 1 |
143 | sexuality/body | 1 |
144 | sgx-induced | 2 |
145 | single-quadrupole | 1 |
146 | single/large | 1 |
147 | small-muscle | 2 |
148 | smartphone-supported | 1 |
149 | spla2-iia | 18 |
150 | steam-to-fuel | 1 |
151 | subattogram | 1 |
152 | subliming | 1 |
153 | substrate-product | 1 |
154 | subtentorial | 1 |
155 | teq/g | 1 |
156 | torque-body | 1 |
157 | torque/body | 1 |
158 | torso-equivalent | 2 |
159 | tripletof | 1 |
160 | trunk-fat | 1 |
161 | unclairified | 1 |
162 | underweight/normal | 5 |
163 | uplc-ltq-orbitrap | 1 |
164 | uplc-q-tof | 1 |
165 | vaquasheen | 1 |
166 | variables-body | 1 |
167 | very-low-birth | 1 |
168 | weight/heart | 1 |
169 | work/body | 1 |
170 | δfat | 2 |
171 | €16/kg | 1 |
1 | pm21 | 1 |
2 | 18,312 | 1 |
3 | 2:1:1.33 | 1 |
4 | 12,476 | 1 |
5 | 53,009 | 1 |
6 | 1-da | 2 |
7 | spla2-iia | 18 |
8 | intestinal-flora | 1 |
9 | koh/c | 1 |
10 | 5975c | 1 |
11 | 2-clbp/rac | 1 |
12 | high-echoic | 1 |
13 | ankylotic | 1 |
14 | lipid-rich/necrotic | 3 |
15 | 150-d | 2 |
16 | sagb-induced | 1 |
17 | mirtazapine-induced | 1 |
18 | lpr-induced | 1 |
19 | sgx-induced | 2 |
20 | body-induced | 1 |
21 | 100-seed | 2 |
22 | unclairified | 1 |
23 | marbled | 1 |
24 | -triolein-labeled | 1 |
25 | olanzapine-associated | 2 |
26 | olanzapine-related | 1 |
27 | risperidone-related | 1 |
28 | menopausal-related | 1 |
29 | multi-lobulated | 1 |
30 | cholesterol/saturated | 2 |
31 | non-evacuated | 1 |
32 | gender-targeted | 1 |
33 | range-weighted | 1 |
34 | liraglutide-augmented | 1 |
35 | smartphone-supported | 1 |
36 | length-adjusted | 1 |
37 | areally-normalized | 1 |
38 | gas/liquid/solid | 1 |
39 | gammarid | 1 |
40 | non-fluid | 1 |
41 | nonfluid | 3 |
42 | rock-hard | 1 |
43 | fat-free | 311 |
44 | rmr/fat-free | 1 |
45 | single/large | 1 |
46 | small-muscle | 2 |
47 | no-muscle | 1 |
48 | single-quadrupole | 1 |
49 | hundred-achene | 1 |
50 | high-bone | 1 |
51 | quantitative/qualitative | 1 |
52 | q-exactive | 2 |
53 | uplc-q-tof | 1 |
54 | tripletof | 1 |
55 | teq/g | 1 |
56 | 1ml/100g | 1 |
57 | 0.5ml/100g | 1 |
58 | 9-kg | 4 |
59 | sb5/kg | 1 |
60 | €16/kg | 1 |
61 | 11kg | 1 |
62 | 0.5±1.02kg | 1 |
63 | fledging | 7 |
64 | subliming | 1 |
65 | heat-transferring | 1 |
66 | pre-sg | 1 |
67 | roundish | 3 |
68 | very-low-birth | 1 |
69 | 100/birth | 1 |
70 | 0-28-wk | 1 |
71 | a=ideal | 1 |
72 | seroperitoneal | 1 |
73 | extra-intracranial | 1 |
74 | subtentorial | 1 |
75 | heat/initial | 2 |
76 | nonlal | 1 |
77 | underweight/normal | 5 |
78 | pelvic-abdominal | 1 |
79 | abdominal/visceral | 1 |
80 | agv/fetal | 1 |
81 | birthweight/placental | 2 |
82 | bw/placental | 1 |
83 | steam-to-fuel | 1 |
84 | oxygen-to-fuel | 1 |
85 | industrial-level | 1 |
86 | attr-fibril | 1 |
87 | fluid-wall | 1 |
88 | grams/kilogram | 1 |
89 | subattogram | 1 |
90 | 1.7×1.4-cm | 1 |
91 | hplc-tandem | 6 |
92 | liquid-chromatography-tandem | 1 |
93 | recovery-room | 3 |
94 | mass/lean | 2 |
95 | body/organ | 1 |
96 | end-permian | 1 |
97 | vaquasheen | 1 |
98 | 1000-grain | 6 |
99 | liquid-chromatography/high-resolution | 1 |
100 | diphoton | 1 |
101 | m/go | 2 |
102 | isotope-ratio | 3 |
103 | bitmap | 1 |
104 | uplc-ltq-orbitrap | 1 |
105 | bar-orbitrap | 1 |
106 | ltq/orbitrap | 1 |
107 | 5-asa/sasp | 1 |
108 | deltacetp | 1 |
109 | medium-molecular | 4 |
110 | macro-molecular | 1 |
111 | low-molecular | 88 |
112 | left‑ventricular | 1 |
113 | immunocellular | 1 |
114 | non-tender | 7 |
115 | fourier-transfer | 1 |
116 | hyper-fever | 1 |
117 | 54±1.3gr | 1 |
118 | interdialysis | 4 |
119 | half-carcass | 1 |
120 | coetaneous | 1 |
121 | placenta-fetus | 1 |
122 | trunk-fat | 1 |
123 | mass/fat | 2 |
124 | deltafat | 1 |
125 | δfat | 2 |
126 | postcontract | 1 |
127 | substrate-product | 1 |
128 | membrane-inlet | 1 |
129 | quadrupole-time-of-flight | 6 |
130 | pain-dependent | 1 |
131 | energy-nutrient | 1 |
132 | torso-equivalent | 2 |
133 | weight/heart | 1 |
134 | secretory-burst | 3 |
135 | lge/lv | 1 |
136 | lv-rv | 1 |
137 | body | 36,671 |
138 | age-body | 1 |
139 | gene-body | 3 |
140 | torque-body | 1 |
141 | normal-body | 1 |
142 | lung-to-body | 3 |
143 | liver-to-body | 3 |
144 | heart-to-body | 3 |
145 | lv-to-body | 2 |
146 | variables-body | 1 |
147 | results-body | 1 |
148 | femininity-body | 2 |
149 | obesity-body | 2 |
150 | pad/body | 1 |
151 | dose/body | 1 |
152 | torque/body | 1 |
153 | g/kg/body | 1 |
154 | growth/body | 1 |
155 | work/body | 1 |
156 | lvm/body | 3 |
157 | organ/body | 2 |
158 | ghrelin/body | 1 |
159 | liver/body | 5 |
160 | heart/body | 4 |
161 | lv/body | 7 |
162 | ecw/body | 1 |
163 | sexuality/body | 1 |
164 | bw=body | 1 |
165 | deltabody | 3 |
166 | prebody | 1 |
167 | 5000mg/kgbody | 1 |
168 | postbody | 1 |
169 | 0.44×body | 1 |
170 | endo-urology | 1 |
171 | normal/healthy | 2 |